Skip to main content
. 2019 Jun 3;21(7):901–910. doi: 10.1093/neuonc/noz061

Fig. 2.

Fig. 2

RFS analysis of the first validation cohort (A), second validation cohort (B), and (C) third validation cohort using the 5-year methylome-based RFS predictor, based on separation into distinct risk groups by median.